By Cristina Roca 
 

Bayer AG said Tuesday that it will spend more than 400 million euros ($464.8 million) to expand its production capabilities as part of its goal of increasing access to contraception for women in less wealthy countries.

The German pharmaceutical-and-chemical conglomerate will build a new production facility in Alajuela, Costa Rica. It will also build a new facility and expand its production capability in Turku, Finland, the company said.

Both sites will produce hormonal implants and hormonal intrauterine systems, and will support the company's goal of giving 100 million women in low- and middle-income countries access to family planning by 2030, Bayer said.

 

Write to at cristina.roca@wsj.com

 

(END) Dow Jones Newswires

October 05, 2021 03:05 ET (07:05 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024 Click aqui para mais gráficos Bayer.
Bayer (TG:BAYN)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024 Click aqui para mais gráficos Bayer.